Canada Markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
599.45-8.62 (-1.42%)
At close: 04:00PM EST
596.79 -2.66 (-0.44%)
After hours: 06:43PM EST
Sign in to post a message.
  • G
    Greg
    Buying opportunity.
  • D
    DON
    Why the selloff in IDXX today ?
  • B
    Brian
    I have to be bullish on IDXX
  • J
    JD
    why is this up post close?
  • J
    Jabberwonky
    Looking strong again, gaining momentum.
  • j
    jere
    Down 100 in the last month?
  • j
    jere
    insider sales?
  • W
    Winorlose
    Worth $54BB, only has $232mm cash!
    Total INSANITY value!!!
  • t
    tkdtmd400
    what's mean ?
    Market : Nasdaq
    Tiker : INMD
    Country : Israel
    Company : INMODE Ltd
    Skin laser
    Revenue : +Growth
    Net INcome : +Growth
  • J
    Jabberwonky
    Oh wow, 5% drop, I'm so scared....
  • F
    Funisnumberone
    Any ideas on what the drop is about today? Just regular profit taking?
  • D
    Da1
    $ZOM conversation
    $ZOM is going to be the rockstar of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas, BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.

    Their new CEO Robert Cohen turned 3 companies from a 0.30 cent stock to $8, and it was already predicted before his appointment that $ZOM would become an at least $3 stock.

    YESTERDAY they applied for a Trademark for MYTRUEFORMA. Paperwork is online.

    TODAY a new Truforma webpage is up on their site, also pictures of packaging, and pre-orders are being placed at the moment. PR news could drop soon and help $ZOM reach new highs. This information has yet to catch up with the rest of the market.

    Realistic bottom right now (before any news hits) is 0.68-0.70 in my opinion, and I believe if you manage to buy around that price you should expect decent profits in the Medium to Long Term.
  • P
    Preston
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.
  • P
    Preston
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation. GLTA
  • B
    Bagholder
    $ZOM conversation
    $ZOM is going to be the rockstar of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.

    They applied for a Trademark today for MYTRUEFORMA. Like this morning January 13th that went in. Paperwork is online.

    The CEO has taken 3 previous companies from .30 to over $8 in his career. This is not his first rodeo.
  • P
    Preston
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.
  • G
    Guy
    How is IDEXX positioned to outcompete competitors? I really like this company but I’m just being cautious as there are other small companies like Lexagene LXG that seem to have a pretty solid game plan. Just looking for people to give me s reason to hold off investing even more in IDEXX.
  • W
    Walt
    $ZOM conversation
    $ZOM $IDXX Do I think the market will see further corrections? Most likely. Do I think ZOM will pull through regardless? Not just yes, but a RESOUNDING yes! Positive sales and new product info are going to bring us to new highs well within the year. Patience is the name of the game here people, and our new CEO knows what he is doing. We just got Miller distribution, a larger global accounting firm, and one of Zomedica's SEVERAL game changing products is finally about to release! Personally I will continue to buy any dips, and I think it's a poor time to sell. Things will rebound fast.
  • S
    S
    What's the reason for the spike up today? Definitely not complaining, but I can't find any info that would cause the jump.
  • N
    N
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.

    The target SP by March this year is at least $10 and above.